Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany....
Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management....
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine....
Authority to Operate (ATO) certification from the U.S. Department of Defense affirms Dräger’s leadership in safeguarding patient data, delivering a fully ATO-certified anesthesia portfolio trusted by hospitals worldwide....
BD’s Urology and Critical Care and Surgery units achieve top-tier recognition from the Healthcare Industry Resilience Collaborative, affirming its leadership in supply chain transparency, risk mitigation, and operational excellence...
The expansion at its Nebraska facility will boost syringe output by hundreds of millions annually, enhancing supply resilience and supporting safe, high-quality patient care across U.S. hospitals....
In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead. ...
With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care....
Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies. ...
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage. ...
